SLN Detection With Tc-MSA-ICG in Lung Cancer Patients
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
It is necessary to develop a technique of sentinel lymph node detection using radioactive
fluorescent dual contrast agent consisting targetable albumin for specific marker to
accurately determine whether or not the sentinel lymph nodes have metastasized or
non-metastasized. Therefore, investigators would like to conduct a clinical trial to evaluate
the effectiveness of radioactive fluorescent dual contrast agent to detect sentinel lymph
nodes for patient-specific minimally invasive surgery.